Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Davidson

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Depression and Anxiety|August 14, 2020
The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trialJames A Blumenthal, Michael A Babyak, Wade Edward Craighead, et al.
Scientific Data|July 21, 2020
A comprehensive, multisource database for hydrometeorological modeling of 14,425 North American watershedsRichard Arsenault, François Brissette, Jean-Luc Martel, et al.
Australian and New Zealand Journal of Public Health|January 19, 2010
A whole of population-based series of radical prostatectomy in Victoria, 1995 to 2000Damien Bolton, Gianluca Severi, Jeremy L Millar, et al.
BJU International|July 16, 2015
Predictors of prostate cancer specific mortality after radical prostatectomy: 10 year oncologic outcomes from the Victorian Radical Prostatectomy RegistryDamien M Bolton, Nathan Papa, Anthony D Ta, et al.
Human Psychopharmacology|May 15, 2008
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studiesJonathan Davidson, Christer Allgulander, Mark H Pollack, et al.
JAMA Psychiatry|August 18, 2021
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical TrialJames A Blumenthal, Patrick J Smith, Wei Jiang, et al.
Journal of Cardiovascular Development and Disease|October 26, 2022
Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical TrialJames A Blumenthal, Patrick J Smith, Wei Jiang, et al.
American Heart Journal|May 24, 2022
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trialJames A Blumenthal, Patrick J Smith, Wei Jiang, et al.
Stroke|June 10, 2021
Clinical Effectiveness of the Queen Square Intensive Comprehensive Aphasia Service for Patients With Poststroke AphasiaAlexander P Leff, Sarah Nightingale, Beth Gooding, et al.
American Heart Journal|June 7, 2016
Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trialJames A Blumenthal, Bryan J Feger, Patrick J Smith, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Depression and Anxiety|August 14, 2020
The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trialJames A Blumenthal, Michael A Babyak, Wade Edward Craighead, et al.
Scientific Data|July 21, 2020
A comprehensive, multisource database for hydrometeorological modeling of 14,425 North American watershedsRichard Arsenault, François Brissette, Jean-Luc Martel, et al.
Australian and New Zealand Journal of Public Health|January 19, 2010
A whole of population-based series of radical prostatectomy in Victoria, 1995 to 2000Damien Bolton, Gianluca Severi, Jeremy L Millar, et al.
BJU International|July 16, 2015
Predictors of prostate cancer specific mortality after radical prostatectomy: 10 year oncologic outcomes from the Victorian Radical Prostatectomy RegistryDamien M Bolton, Nathan Papa, Anthony D Ta, et al.
Human Psychopharmacology|May 15, 2008
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studiesJonathan Davidson, Christer Allgulander, Mark H Pollack, et al.
JAMA Psychiatry|August 18, 2021
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical TrialJames A Blumenthal, Patrick J Smith, Wei Jiang, et al.
Journal of Cardiovascular Development and Disease|October 26, 2022
Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical TrialJames A Blumenthal, Patrick J Smith, Wei Jiang, et al.
American Heart Journal|May 24, 2022
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trialJames A Blumenthal, Patrick J Smith, Wei Jiang, et al.
Stroke|June 10, 2021
Clinical Effectiveness of the Queen Square Intensive Comprehensive Aphasia Service for Patients With Poststroke AphasiaAlexander P Leff, Sarah Nightingale, Beth Gooding, et al.
American Heart Journal|June 7, 2016
Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trialJames A Blumenthal, Bryan J Feger, Patrick J Smith, et al.
Pageof 6